profit from every $100 of sales.
$0$100
SANUWAVE Health
$1.82+15.19% today
-94.6% in 1 year
1-year low $1.581-year high $35.03
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $1.33 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What SANUWAVE Health sold, what it kept, and what it did with the cash.
Sales went from $16.7 million in 2022 to $44.1 million in 2025, with $11.8 million of profit last year.
SalesProfit
SANUWAVE Health vs. similar companies
SANUWAVE Health grows the fastest of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| SANUWAVE Health | 1.3× · Cheap | ||
 Boston Scientific | 22.2× · Fair price | ||
 Koninklijke Philips | 30.1× · Expensive | ||
 Steris | 32.8× · Expensive | ||
 Zimmer Biomet Holdings | 27.7× · Fair price |
AI analysis
An AI analyst reads SANUWAVE Health's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 17 | 20 | 33 | 44 | |
| 12 | 14 | 25 | 34 | |
| -9 | -1 | 4 | 5 | |
| 5 | -9 | -18 | 19 | |
| -10 | -26 | -33 | 12 | |
| -7.50 | -12.19 | -7.03 | 0.41 | |
| 74.1% | 70.4% | 75.2% | 77.1% | |
| -53.5% | -2.6% | 11.8% | 11.2% | |
| -61.5% | -126.5% | -101.4% | 26.8% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 20 | 22 | 30 | 37 |
| Cash | 1 | 2 | 10 | 12 |
| Total debt | 39 | 30 | 26 | 23 |
| Total liabilities | 61 | 66 | 46 | 36 |
| -41 | -43 | -16 | 2 | |
| 1 | 2 | 4 | 9 | |
| – | – | -152.3% | 58.3% | |
| 25.1% | 59.8% | 209.5% | 729.6% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -17 | -5 | 2 | 4 | |
| – | – | 0 | 2 | |
| -17 | -5 | 2 | 2 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| – | 0 | 2 | 5 |
Valuation
- 1.3×
- 1.9×
- –
- 75.0×
- 0.4×
- 8.1×
- 1.4×
- 12.4%
- 75.5%
- 0.0%
Profitability
- 77.1%
- 11.2%
- 26.8%
- 20.1%
- 11.4%
- 153.8%
- -450.6%
- 43.3%
- 15.1%
- 4.1%
Growth
- +38.1%
- –
- −1.6%
- –
- +57.8%
Financial health
- 0.6×
- 3.91
- 19.4%
- 0.7×
- 1.31
- 0.99
- 1.19
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 24%of 963
Top 47%of 894
Top 1%of 632
Top 14%of 908
Top 5%of 991
What analysts expect
- Average price target
- $54.00
- Range
- $53.00 – $55.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 12, 2026 | -0.17 | -0.14 | −21.4% |
| Mar 26, 2026 | 0.03 | 0.17 | −82.4% |
| Nov 7, 2025 | 0.46 | 0.32 | +43.8% |
| Aug 8, 2025 | 0.01 | -0.09 | +111.1% |
| May 9, 2025 | -0.66 | – | – |
| Mar 20, 2025 | -1.21 | – | – |
| Nov 7, 2024 | -6.49 | – | – |
| Aug 12, 2024 | 3.70 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
3/7Passes 3 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
57No pass
Benjamin Graham
39No pass
Philip Fisher
71Pass
Peter Lynch
75Pass
Joel Greenblatt
70Pass
Charlie Munger
59No pass
Terry Smith
59No pass
Questions about SANUWAVE Health
Is SANUWAVE Health a good stock to buy?
A strong, very profitable business, and the price looks low. 3 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the SANUWAVE Health AI analysis
What does SANUWAVE Health do?
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. It is in Medical - Devices.
Does SANUWAVE Health pay a dividend?
No. SANUWAVE Health does not pay a dividend at the moment.
Is SANUWAVE Health stock halal?
No. SANUWAVE Health does not pass our halal screen: its debt is 147% of its market value, at or above the 33% limit. How we check
How has SANUWAVE Health stock done over the past year?
Down 94.6% over the past twelve months, to $1.82. It traded between $1.58 and $35.03 and is 94.8% below its high.
Who are SANUWAVE Health's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with SANUWAVE Health's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.